5. Results of Clinical Trials Can Be Explained by APP-Independent and BACE Inhibition-Insensitive Generation of Beta Amyloid in Sporadic Alzheimer’s Disease. Here, APP is linked to early-onset autosomal dominant Alzheimer disease.